Food News and Research

RSS

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

The U.S. Food and Drug Administration today approved Xiaflex (collagenase clostridium histolyticum) as the first drug to treat a progressive hand disease known as Dupuytren's contracture, which can affect a person's ability to straighten and properly use their fingers.

2 Feb 2010

FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA

Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration (“FDA”) for its Abbreviated New Drug Application (“ANDA”) for Levetiracetam Tablets, 250 mg, 500 mg, 750 mg and 1000 mg (“levetiracetam tablets”).

2 Feb 2010

Contemporary version of We Are The World song recorded to benefit Haitian earthquake relief efforts

Producer Quincy Jones and singer/songwriter Lionel Richie, the producer and co-writer of the iconic 1985 philanthropic anthem We Are The World, have confirmed that they have teamed with producer/musician Wyclef Jean and Grammy-winning producer RedOne and producer/musical director Ricky Minor in association with Randy Phillips, President & CEO, AEG Live to record a contemporary version of the song to benefit the Haitian earthquake relief efforts on Monday, February 1, 2010.

2 Feb 2010

New formulated soy product offers heart health benefits

Just in time for Heart Health Month, EcoNugenics introduces the newest in their scientifically formulated product line: CIRCUTOL™ Cardiovascular Health Support.

2 Feb 2010

Long-term harmful effects of BPA exposure: Cereplast lauds FDA's demand for additional study

Cereplast, Inc., manufacturer of proprietary bio-based sustainable plastics, applauds the Food and Drug Administration (FDA) for demanding increased study of the long-term effects of Bisphenol A (BPA) exposure.

2 Feb 2010

Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S

Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has entered into a co-development and commercialization agreement with TopoTarget A/S for Belinostat, a novel histone deacetylase (HDAC) inhibitor.

2 Feb 2010

Researchers identify 1.1M base pairs of DNA in soybean genome

In 2009, soybeans represented an almost $30 billion industry in the U.S. alone, making soybeans the second-most profitable crop next to corn. Worldwide, soybeans have been used in human foods and livestock feed for centuries and have been a key component in industrial products, such as plastics and soy biodiesel, an environmentally friendly fuel.

2 Feb 2010

FDA requests additional data on CMC section of NDA for taliglucerase alfa from Protalix BioTherapeutics

Protalix BioTherapeutics, Inc. announced today that, in connection with the New Drug Application (NDA) filed by the Company in December 2009 for taliglucerase alfa for the treatment of Gaucher disease, the U.S. Food and Drug Administration (FDA) has requested additional data regarding the Chemistry, Manufacturing and Controls (CMC) section of the NDA.

2 Feb 2010

Millennials overly optimistic about their health despite unhealthy habits

According to Life University, a leading chiropractic college and vital health university, Millennials (ages 15-27), are overly optimistic about their own health, despite admitting to the same unhealthy habits that have caused chronic illness in previous generations.

2 Feb 2010

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

Rising consumer awareness that early diagnosis and treatment can delay the progression of human immunodeficiency virus (HIV) to anti-immuno deficiency syndrome (AIDS) has had a telling impact on the sales of HIV tests.

2 Feb 2010

New product recall system for food and consumer product industries

FoodTrack Inc., an industry leader that provides early and pre-incident advisories for recalls, outbreaks and similar events that adversely impact the food and consumer product industries, announced today the development of a new, patent pending product recall system designed to mitigate risk, protect consumer health and improve the effectiveness of the product recall process.

2 Feb 2010

First annual Translational Regenerative Medicine Forum to be held in Winston-Salem

The Regenerative Medicine Foundation today announced the first annual Translational Regenerative Medicine Forum to be held April 6-8, 2010 at the Benton Convention Center in Winston-Salem.

2 Feb 2010

Also in Global Health News: Retrovirus enzyme; audit of USAID program; Africa's agriculture

A study published on Sunday in the journal Nature has shed light on the enzyme integrase, "which is found in retroviruses like HIV and is a target for some of the newest HIV medicines," Reuters reports. Scientists at the Imperial College London and Harvard University grew a crystal of integrase in the lab allowing them to see the enzyme's structure. According to the news service, the scientists "said that having the integrase structure means researchers can begin fully to understand how integrase inhibitor drugs work, how they might be improved, and how to stop HIV developing resistance to them," according to the news service (Kelland, 2/1).

2 Feb 2010

Suzhou Erye Pharmaceutical receives Chinese SFDA approval for manufacturing penicillin at new facility

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that it recently was advised that its Suzhou Erye Pharmaceutical subsidiary ("Erye") received approval from the State Food and Drug Administration (SFDA) in China to manufacture solvent crystallization sterile penicillin and freeze dried raw sterile penicillin at their new facility which provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility. Historically, these two lines have accounted for approximately 20% of Erye's sales.

2 Feb 2010

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

Researchers at National Jewish Health have discovered how the virulent food-borne bacteria Listeria monocytogenes induces infected immune cells to sabotage their own defensive response.

2 Feb 2010

Findings could lead to new therapeutic strategies for obesity

Peptides that target blood vessels in fat and cause them to go into programmed cell death (termed apoptosis) could become a model for future weight-loss therapies, say University of Cincinnati (UC) researchers.

2 Feb 2010

U.S. government resumes medical evacuations from Haiti; new food voucher distribution targeting women begins

"The U.S. government said on Sunday it would resume military evacuation flights" within 12 hours for critically ill and injured Haitians who were harmed in the Jan. 12 earthquake, Reuters reports (Rosenberg/Brown, 1/31). Medical evacuations had been suspended for a few days, but the reason for the suspension "is unclear as various government authorities have provided different explanations," the Wall Street Journal reports.

2 Feb 2010

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President's fiscal year 2011 budget - a 23 percent increase over the agency's current $3.28 billion budget.

2 Feb 2010

SDI selected for third consecutive time as key monoclonal antibody provider

SDI (Strategic Diagnostics Inc.), a leading provider of biotechnology-based products and services for a broad range of life science, food safety, and industrial applications, today announced it has been selected again by Science Applications International Corporation - Frederick (SAIC-F) to develop monoclonal antibodies for the National Cancer Institute’s “Clinical Proteomic Technologies for Cancer” initiative (CPTC: http://proteomics.cancer.gov).

2 Feb 2010

ADA's position paper addresses nutrition aspects of health care for people with developmental disabilities

The American Dietetic Association has published an updated position paper that addresses the nutrition aspects of health care for people with developmental disabilities and special health care needs.

2 Feb 2010

Food News and Research

Xiaflex receives FDA approval for treatment of Dupuytren's contracture

FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA

Contemporary version of We Are The World song recorded to benefit Haitian earthquake relief efforts

New formulated soy product offers heart health benefits

Long-term harmful effects of BPA exposure: Cereplast lauds FDA's demand for additional study

Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S

Researchers identify 1.1M base pairs of DNA in soybean genome

FDA requests additional data on CMC section of NDA for taliglucerase alfa from Protalix BioTherapeutics

Millennials overly optimistic about their health despite unhealthy habits

Overview of newly evolving technologies for diagnosing and monitoring HIV infections

New product recall system for food and consumer product industries

First annual Translational Regenerative Medicine Forum to be held in Winston-Salem

Also in Global Health News: Retrovirus enzyme; audit of USAID program; Africa's agriculture

Suzhou Erye Pharmaceutical receives Chinese SFDA approval for manufacturing penicillin at new facility

Studies suggest potential therapeutic targets for food poisoning, TB and autoimmune diseases

Findings could lead to new therapeutic strategies for obesity

U.S. government resumes medical evacuations from Haiti; new food voucher distribution targeting women begins

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

SDI selected for third consecutive time as key monoclonal antibody provider

ADA's position paper addresses nutrition aspects of health care for people with developmental disabilities

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News